No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9329191 |
chr8:9216584-9216585 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs556961912 |
chr8:9216628-9216629 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs9329192 |
chr8:9216647-9216648 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs185689448 |
chr8:9216648-9216649 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs113474717 |
chr8:9216653-9216654 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs572167218 |
chr8:9216665-9216666 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs370887299 |
chr8:9216680-9216681 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs541130694 |
chr8:9216691-9216692 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs548173479 |
chr8:9216701-9216702 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs533171923 |
chr8:9216702-9216703 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs543832613 |
chr8:9216710-9216711 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs563806133 |
chr8:9216722-9216723 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs188684667 |
chr8:9216752-9216753 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs28541420 |
chr8:9216759-9216760 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs28394733 |
chr8:9216764-9216765 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs369352857 |
chr8:9216766-9216767 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs80329816 |
chr8:9216830-9216831 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs200911427 |
chr8:9216876-9216877 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs528143908 |
chr8:9216883-9216884 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs180713016 |
chr8:9216906-9216907 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs571402571 |
chr8:9216907-9216908 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs12550199 |
chr8:9216924-9216925 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
23 |
rs367841494 |
chr8:9216928-9216929 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs556966897 |
chr8:9216934-9216935 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs530648673 |
chr8:9216946-9216947 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs78051589 |
chr8:9216948-9216949 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs186007234 |
chr8:9216960-9216961 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs148909394 |
chr8:9216962-9216963 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs2169384 |
chr8:9216986-9216987 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs541093913 |
chr8:9217037-9217038 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs557812738 |
chr8:9217076-9217077 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs192162054 |
chr8:9217111-9217112 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs4345557 |
chr8:9217123-9217124 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
34 |
rs370214265 |
chr8:9217127-9217128 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs563738937 |
chr8:9217144-9217145 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs141129892 |
chr8:9217147-9217148 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs186397779 |
chr8:9217150-9217151 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs559956986 |
chr8:9217191-9217192 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs1381350 |
chr8:9217195-9217196 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
40 |
rs570961419 |
chr8:9217216-9217217 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs111817600 |
chr8:9217219-9217220 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs190496045 |
chr8:9217225-9217226 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs540034708 |
chr8:9217265-9217266 |
Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs552033598 |
chr8:9217280-9217281 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs553643954 |
chr8:9217295-9217296 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs182902054 |
chr8:9217308-9217309 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs4507762 |
chr8:9217339-9217340 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs554962536 |
chr8:9217342-9217343 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs550267533 |
chr8:9217347-9217348 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs150992886 |
chr8:9217348-9217349 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|